MIF and lung cancer: The authors used an experimental setup to study lung cancer and showed that WGP-treated mouse macrophages and human monocytes exhibited a trained enhanced response upon direct contact with tumor cells or exposure to tumor-derived soluble factors, such as macrophage migration inhibitory factor (MIF).